Perrigo Company plc OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, Tax
Perrigo Company plc (PRGO) reported OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, Tax of $500.00 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-01.
Discontinued › Expense Statement › Income Tax
us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax · last filed 2018-03-01
- Perrigo Company plc oci, debt securities, available-for-sale, gain (loss), after adjustment, tax for the quarter ending 2014-09-27 was $300.00K.
- Perrigo Company plc oci, debt securities, available-for-sale, gain (loss), after adjustment, tax for the quarter ending 2013-09-28 was $0.00.
- Perrigo Company plc oci, debt securities, available-for-sale, gain (loss), after adjustment, tax for fiscal 2017 was $500.00K.
- Perrigo Company plc oci, debt securities, available-for-sale, gain (loss), after adjustment, tax for fiscal 2016 was -$4.10M.
- Perrigo Company plc oci, debt securities, available-for-sale, gain (loss), after adjustment, tax for fiscal 2015 was $2.70M, a 125.00% increase from fiscal 2014.
- Perrigo Company plc oci, debt securities, available-for-sale, gain (loss), after adjustment, tax for fiscal 2014 was $1.20M.
| Period end | OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, Tax 3 month | OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, Tax 6 month | OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, Tax 6 month as first filed | OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, Tax 12 month | OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, Tax 12 month as first filed |
|---|---|---|---|---|---|
| 2017-12-31 | $500.00K 10-K · filed 2018-03-01 | ||||
| 2016-12-31 | -$4.10M 10-K · filed 2018-03-01 | $4.10M 10-K · filed 2017-05-22 | |||
| 2015-12-31 | -$3.60M 10-K · filed 2018-03-01 | $3.60M 10-KT · filed 2016-02-25 | |||
| 2015-06-27 | $2.70M 10-K · filed 2018-03-01 | -$2.70M 10-K · filed 2015-08-13 | |||
| 2014-09-27 | $300.00K 8-K · filed 2014-11-20 | ||||
| 2014-06-28 | $1.20M 10-K · filed 2017-05-22 | ||||
| 2013-09-28 | $0.00 8-K · filed 2014-11-20 | ||||
| 2013-06-29 | $0.00 10-KT · filed 2016-02-25 | ||||
| 2012-06-30 | $100.00K 10-K · filed 2014-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |